Article
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
Molecular psychiatry - 1 Jan 2016
van Bon B W M, Coe B P, Bernier R, Green C, Gerdts J, Witherspoon K, Kleefstra T, Willemsen M H, Kumar R, Bosco P, Fichera M, Li D, Amaral D, Cristofoli F, Peeters H, Haan E, Romano C, Mefford H C, Scheffer I, Gecz J, de Vries B B A, Eichler E E
Abstract excerpt
Dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1 A (DYRK1A) maps to the Down syndrome critical region; copy number increase of this gene is thought to have a major role in the neurocognitive deficits associated with Trisomy 21. Truncation of DYRK1A in patients with developmental delay (DD) and autism spectrum disorder (ASD) suggests a different pathology associated with loss-of-function mutations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
